Studying kidney health in young people with type 2 diabetes during puberty
Studies kidney function in children with obesity, prediabetes or type 2 diabetes during puberty.
Key facts
- Who runs it
- Petter Bjornstad
- Where
- Aurora and Seattle, United StatesSee the 2 sites
- Trial code
- Registry title
- Puberty, Diabetes, and the Kidneys, When Eustress Becomes Distress (PANTHER Study)
- Status
- Recruiting
- People taking part
- 100 people, planned
- Started
- 27 Sept 2021
- Expected to end
- 1 Dec 2027
- Type of study
- Observational, 2 groups
- Treatments tested
- Aminohippurate Sodium Inj 20%
- Iohexol Inj 300 MG/ML
- Dextran 40
- Record updated
- 24 March 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for children and teenagers aged 8 to 14 years. Some have high blood sugar and a higher body weight. Others are a control group with normal blood sugar.
- Age
- 8 to 14 years
- Sex
- All sexes can join.
- Disease stage
- High-risk group: HbA1c ≥6.0% (42 mmol/mol) without treatment and BMI ≥ 85th percentile. Control group: normal HbA1c ≤5.6% (38 mmol/mol).
- Earlier treatment
- The high-risk group must not be on treatment for high blood sugar (untreated HbA1c ≥6.0% (42 mmol/mol)).
- Biomarker or test result
- Type 1 diabetes antibody test must be negative.
Main reasons for not taking part
- History of chronic kidney disease or acute kidney injury
- Metabolic disorder that makes fasting unsafe
- Iodine or penicillin allergy
- Pregnancy
- Thrombophilia, MRI contraindications or hormone therapy
The registry criteria, word for word
Show all 11 criteriaShow less
Who can take part
- HbA1c ≥6.0% for untreated high-risk group
- BMI ≥ 85th %ile for high-risk group
- Normal HbA1c ≤5.6% for control group
- Type 1 diabetes (T1D) Antibody negative
Who cannot take part
- Hormone therapy
- History of Chronic kidney disease (CKD) or acute kidney injury (AKI)
- Metabolic disorder prohibiting safe fasting
- Iodine or penicillin allergy
- Pregnancy
- Thrombophilia
- MRI contraindications
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 8 and 14 years old?
Where in United States
- Children's Hospital ColoradoAurora, United StatesContact: Megan Kelsey, MD, MSTaking people
- Seattle Children's HospitalSeattle, United StatesContact: Petter M Bjornstad, MDTaking people
About the trial
What the trial wants to find out
Early diabetic kidney disease (DKD) occurs in 50-70% of youth with type 2 diabetes (T2D) and confers high lifetime risk of dialysis and premature death. Youth-onset T2D typically manifests during or shortly after puberty in adolescents with obesity. Epidemiological data implicate puberty as an accelerator of kidney disease in youth with obesity and diabetes and the investigators posit that the link between puberty and T2D-onset may explain the high burden of DKD in youth-onset T2D. A better understanding of the impact of puberty on kidney health is needed to promote preservation of native kidney function, especially in youth with T2D.
The 2 groups in the trial
- Youth with overweight/obesity and/or newly diagnosed T2D and elevated HbA1c
All participants will undergo GFR (Iohexol Inj 300 MG/ML), EPRF (Aminohippurate Sodium Inj 20%), Dextran sieving (Dextran 40 Sodium Inj 0.9%), IVGTT for insulin sensitivity, in addition to BOLD and ASL Kidney MRI
Treatment: Aminohippurate Sodium Inj 20%, Iohexol Inj 300 MG/ML, and Dextran 40
- Healthy normal-weight controls
All participants will undergo GFR (Iohexol Inj 300 MG/ML), EPRF (Aminohippurate Sodium Inj 20%), Dextran sieving (Dextran 40 Sodium Inj 0.9%), IVGTT for insulin sensitivity, in addition to BOLD and ASL Kidney MRI
Treatment: Aminohippurate Sodium Inj 20%, Iohexol Inj 300 MG/ML, and Dextran 40
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- PANTHER Study: Puberty, Diabetes, and the Kidneys, When Eustress Becomes Distress
- Plain-language title
- Studying kidney health in young people with type 2 diabetes during pubertyGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT05008276, who can take part
- Record updated
- 24 March 2025